Featured Post
Monsters Are Real
JDRF Canada has a plan to defeat the T1D monster that burdens 300,000 Canadians.
Read More

New Quebec registry tracks hypoglycemia among diabetes patients to help reduce risks

Dr. Rémi Rabasa-Lhoret, a JDRF-funded endocrinologist at the Institut de recherches cliniques de Montréal best known for his work on the artificial pancreas, is overseeing the initiative to collect data for the Quebec-wide registry of people with T1D in order to track the incidence of hypoglycemic episodes and allow patients to better manage their disease.

Exploring oral therapy to safeguard beta cells and treat type 1 diabetes

Administering insulin on a daily basis can be a tedious task, particularly among individuals newly diagnosed with type 1 diabetes (T1D). To mitigate this, researchers are currently experimenting with islet (insulin-producing cells) transplantation as a promising therapy that eliminates the need for insulin injections.

Stay connected on the latest


Help Us Create a World Without Type 1 Diabetes

Give Now